{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:14:50Z","timestamp":1790716490105,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Neuropathic pain is often associated with depression. Enhancing endocannabinoids by fatty acid amide hydrolase (FAAH) inhibitors relieves neuropathic pain and stress-induced depressive-like behaviors in animal models. However, it is unclear whether FAAH inhibitor can relieve neuropathic pain\u2013induced depression by or not by its antinociceptive effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      Adult male Wistar rats with chronic constriction injury (CCI) to the sciatic nerve were treated with the systemic FAAH inhibitor URB597 (5.8 mg\u00b7kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      \u00b7day\n                      <jats:sup>\u22121<\/jats:sup>\n                      , intraperitoneally) or peripherally acting FAAH inhibitor URB937 (1.6 mg\u00b7kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      \u00b7d\n                      <jats:sup>\u22121<\/jats:sup>\n                      , intraperitoneally; n = 11\u201312). The treatment was applied from the 15th day after surgery and continued for 15 days. Mechanical withdrawal threshold was examined by Von Frey test before surgery and on the 28th day after CCI. Depressive-like behaviors were evaluated by forced swimming test (FST) and novelty-suppressed feeding (NSF) after 15-day treatment. The levels of anandamide and 2-arachidonoylglycerol in hippocampus were examined by liquid chromatography and mass spectrometry. Hippocampal neurogenesis including proliferation, differentiation, and survival of newborn cells was assessed by immunohistochemistry.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      After CCI injury, the rats developed significantly nociceptive and depressive-like behaviors, indicated by persistent mechanical hypersensitivity in Von Frey test, significantly prolonged immobility time in FST (sham: 84.2 \u00b1 13.4 seconds versus CCI: 137.9 \u00b1 18.8 seconds;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001), and protracted latency to feed in NSF (sham: 133.4 \u00b1 19.4 seconds versus CCI: 234.9 \u00b1 33.5 seconds;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). For the CCI rats receiving treatment, compared to vehicle placebo group, pain threshold was increased by both URB597 (3.1 \u00b1 1.0 vs 11.2 \u00b1 1.2 g;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) and URB937 (3.1 \u00b1 1.0 vs 12.1 \u00b1 1.3 g;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). Immobility time of FST was reduced by URB597 (135.8 \u00b1 16.6 vs 85.3 \u00b1 17.2 seconds;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) but not by URB937 (135.8 \u00b1 16.6 vs 129.6 \u00b1 17.8 seconds;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .78). Latency to feed in NSF was also reduced by URB597 (235.9 \u00b1 30.5 vs 131.8 \u00b1 19.8 seconds;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) but not by URB937 (235.9 \u00b1 30.5 vs 232.2 \u00b1 33.2 seconds;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .72). Meanwhile, CCI decreased the number of proliferating cells and reduced survival of new mature neurons in hippocampus. URB597 but not URB937 treatment improved these cellular deficits.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Inhibition of FAAH can improve depressive-like behaviors induced by neuropathic pain independent of its peripheral antinociceptive action. Enhanced neurogenesis in hippocampus might contribute to the antidepressive effects of URB597.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000003563","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T11:23:09Z","timestamp":1527852189000},"page":"587-597","source":"Crossref","is-referenced-by-count":32,"title":["Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain"],"prefix":"10.1213","volume":"129","author":[{"given":"Hai-xia","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, People\u2019s Republic of China"},{"name":"Department of Anesthesiology, The First Affiliated Hospital of Kunming Medical University, Kunming, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-wen","family":"Ke","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, People\u2019s Republic of China"},{"name":"Laboratory of Anesthesia & Critical Care Medicine, Translational Neuroscience Center, West China Hospital of Sichuan University, Chengdu, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, People\u2019s Republic of China"},{"name":"Laboratory of Anesthesia & Critical Care Medicine, Translational Neuroscience Center, West China Hospital of Sichuan University, Chengdu, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, General Hospital of Ningxia Medical University, Yinchuan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-rong","family":"Hai","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The People\u2019s Hospital of Ningxia Hui Nationality Autonomous Region, Yinchuan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-ying","family":"Gong","sequence":"additional","affiliation":[{"name":"Laboratory of Anesthesia & Critical Care Medicine, Translational Neuroscience Center, West China Hospital of Sichuan University, Chengdu, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Core Facility of West China Hospital, Sichuan University, Chengdu, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, People\u2019s Republic of China"},{"name":"Laboratory of Anesthesia & Critical Care Medicine, Translational Neuroscience Center, West China Hospital of Sichuan University, Chengdu, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230721","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1176\/ps.2009.60.3.344","article-title":"Relationships among depression, chronic pain, chronic disabling pain, and medical costs.","volume":"60","author":"Arnow","year":"2009","journal-title":"Psychiatr Serv"},{"key":"R2-20230721","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/ALN.0b013e3182657b3e","article-title":"Depressive-like states heighten the aversion to painful stimuli in a rat model of comorbid chronic pain and depression.","volume":"117","author":"Bravo","year":"2012","journal-title":"Anesthesiology"},{"key":"R3-20230721","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.biopsych.2011.07.017","article-title":"A time-dependent history of mood disorders in a murine model of neuropathic pain.","volume":"70","author":"Yalcin","year":"2011","journal-title":"Biol Psychiatry"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.pain.2009.02.018","article-title":"Depression-like behaviour in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833.","volume":"143","author":"Hu","year":"2009","journal-title":"Pain"},{"key":"R5-20230721","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol"},{"key":"R6-20230721","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/pr.112.006387","article-title":"Chemical probes of endocannabinoid metabolism.","volume":"65","author":"Blankman","year":"2013","journal-title":"Pharmacol Rev"},{"key":"R7-20230721","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"},{"issue":"suppl 1","key":"R8-20230721","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.pain.2013.03.023","article-title":"Endocannabinoids: a unique opportunity to develop multitarget analgesics.","volume":"154","author":"Maione","year":"2013","journal-title":"Pain"},{"key":"R9-20230721","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1172\/JCI25509","article-title":"Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects.","volume":"115","author":"Jiang","year":"2005","journal-title":"J Clin Invest"},{"key":"R10-20230721","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.neuropharm.2013.10.006","article-title":"Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB1 and CB2 receptors.","volume":"77","author":"Desroches","year":"2014","journal-title":"Neuropharmacology"},{"key":"R11-20230721","doi-asserted-by":"crossref","first-page":"13318","DOI":"10.1523\/JNEUROSCI.3326-06.2006","article-title":"Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain.","volume":"26","author":"Jhaveri","year":"2006","journal-title":"J Neurosci"},{"key":"R12-20230721","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/jpet.109.155465","article-title":"Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.","volume":"330","author":"Kinsey","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"R13-20230721","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.107.119941","article-title":"The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3\u2019-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.","volume":"322","author":"Russo","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"R14-20230721","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.biopsych.2006.12.001","article-title":"Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress.","volume":"62","author":"Bortolato","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R15-20230721","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nn.2632","article-title":"Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.","volume":"13","author":"Clapper","year":"2010","journal-title":"Nat Neurosci"},{"key":"R16-20230721","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants.","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"R17-20230721","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1017\/S1461145712001502","article-title":"The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.","volume":"16","author":"Campos","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"R18-20230721","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"R19-20230721","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1213\/ANE.0000000000000838","article-title":"Stress increases the negative effects of chronic pain on hippocampal neurogenesis.","volume":"121","author":"Romero-Grimaldi","year":"2015","journal-title":"Anesth Analg"},{"key":"R20-20230721","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly.","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann Appl Biol"},{"key":"R21-20230721","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1213\/01.ane.0000261514.19946.66","article-title":"Experimental neuropathy in mice is associated with delayed behavioral changes related to anxiety and depression.","volume":"104","author":"Suzuki","year":"2007","journal-title":"Anesth Analg"},{"key":"R22-20230721","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw.","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"R23-20230721","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments.","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"R24-20230721","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12576-013-0261-z","article-title":"Emulsified isoflurane postconditioning produces cardioprotection against myocardial ischemia-reperfusion injury in rats.","volume":"63","author":"Hu","year":"2013","journal-title":"J Physiol Sci"},{"key":"R25-20230721","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis.","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R26-20230721","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/ALN.0b013e31822f16ae","article-title":"A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats.","volume":"115","author":"Wang","year":"2011","journal-title":"Anesthesiology"},{"key":"R27-20230721","doi-asserted-by":"crossref","first-page":"12304","DOI":"10.1523\/JNEUROSCI.0312-14.2014","article-title":"Anxiety- and depression-like behavior and impaired neurogenesis evoked by peripheral neuropathy persist following resolution of prolonged tactile hypersensitivity.","volume":"34","author":"Dimitrov","year":"2014","journal-title":"J Neurosci"},{"key":"R28-20230721","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/ALN.0000000000000768","article-title":"Psychiatric comorbidity is associated prospectively with diminished opioid analgesia and increased opioid misuse in patients with chronic low back pain.","volume":"123","author":"Wasan","year":"2015","journal-title":"Anesthesiology"},{"key":"R29-20230721","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1124\/jpet.105.093286","article-title":"Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.","volume":"316","author":"Maione","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"R30-20230721","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.psyneuen.2009.03.013","article-title":"Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.","volume":"34","author":"Hill","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"R31-20230721","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/j.1471-4159.2008.05567.x","article-title":"Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment.","volume":"106","author":"Hill","year":"2008","journal-title":"J Neurochem"},{"key":"R32-20230721","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1189\/jlb.3RU0115-021R","article-title":"Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.","volume":"97","author":"Turcotte","year":"2015","journal-title":"J Leukoc Biol"},{"key":"R33-20230721","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1523\/JNEUROSCI.0587-12.2012","article-title":"Abnormalities in hippocampal functioning with persistent pain.","volume":"32","author":"Mutso","year":"2012","journal-title":"J Neurosci"},{"key":"R34-20230721","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/npp.2014.230","article-title":"Adult neurogenesis and mental illness.","volume":"40","author":"Schoenfeld","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"R35-20230721","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/j.pain.0000000000000332","article-title":"Role of adult hippocampal neurogenesis in persistent pain.","volume":"157","author":"Apkarian","year":"2016","journal-title":"Pain"},{"key":"R36-20230721","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.","volume":"20","author":"Malberg","year":"2000","journal-title":"J Neurosci"},{"key":"R37-20230721","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/mol.66.2.204","article-title":"Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice.","volume":"66","author":"Jin","year":"2004","journal-title":"Mol Pharmacol"},{"key":"R38-20230721","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.nbd.2010.03.020","article-title":"Depression-like phenotype following chronic CB1 receptor antagonism.","volume":"39","author":"Beyer","year":"2010","journal-title":"Neurobiol Dis"},{"key":"R39-20230721","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/hipo.22344","article-title":"Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity.","volume":"25","author":"Zhang","year":"2015","journal-title":"Hippocampus"},{"key":"R40-20230721","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1016\/j.pain.2011.09.013","article-title":"Chronic neuropathic pain-like behavior correlates with IL-1\u03b2 expression and disrupts cytokine interactions in the hippocampus.","volume":"152","author":"del Rey","year":"2011","journal-title":"Pain"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201908000-00042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:19:47Z","timestamp":1786112387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201908000-00042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000003563","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}